Polydatin inhibits LPS-induced inflammatory response in BV2 microglia by disrupting the formation of lipid rafts

Shengyu Sun,Yourui Zou,Shaocai Hao,Zhanfeng Niu,Liang Wu
DOI: https://doi.org/10.1080/08923973.2020.1867999
IF: 3.712
2021-01-28
Immunopharmacology and Immunotoxicology
Abstract:<span>Polydatin has been used in the treatment of various inflammatory diseases. However, its role in the regulation of neuroinflammation has not been reported. In this study, we designed to investigate the anti-inflammatory effects of polydatin in LPS-stimulated BV2 microglia cells.Inflammatory mediators TNF-α, IL-1β, NO, and PGE2 production were measured by ELISA. The protein of signaling pathways were detected by western blot analysis.The results showed that polydatin significantly ameliorated the production of TNF-α, IL-1β, NO, and PGE2 up-regulated by LPS. Polydatin also blocked LPS-induced NF-κB activation. In addition, PI3K and AKT, the up-stream molecules of NF-κB signaling pathway, were inhibited by the treatment of polydatin. Also, we found the formation of lipid rafts was inhibited by polydatin through attenuating the cholesterol content. Finally, polydatin was found to increase the expression of ABCA1 and ABCG1.In conclusion, the results of the present study suggested that polydatin exhibited its anti-inflammatory effects in BV2 cells through disrupting lipid rafts, which subsequently inhibiting PI3K/AKT signaling pathway.</span>
pharmacology & pharmacy,immunology,toxicology
What problem does this paper attempt to address?